Real Life Challenges in Heart Failure Management: weighing co-morbidities and complexities in clinical decisions.

Heart failure (HF) is a clinical syndrome in which a structural and/or functional cardiac abnormality results in reduced cardiac output and/or elevated intracardiac pressures at rest or during stress.

Its underlying cause is often a myocardial abnormality resulting in ventricular dysfunction. However, abnormalities of the valves, pericardium, endocardium, heart rhythm and conduction can also cause HF. Identifying the underlying etiology is essential, as it will determine treatment.

In this two-part virtual clinic and workshops series provided by Howitreat.MD and developed by SEI Healthcare, two renowned Canadian subject matter experts address the optimal, guideline-directed approaches to the management of HF with reduced ejection fraction (HFrEF), in which therapies have been shown to reduce both morbidity and mortality.

Ezekowitz JA et al. 2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Can J Cardiol. 2017;33:1342-1433.

Ponikowski P et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129-2200.

Watch The On-Demand Workshops Activty Here

Target Audience

This activity is intended for Canada-based cardiologists, internists, intensivists, emergency physicians, and other healthcare professionals caring for patients with cardiovascular disease, particularly heart failure.

Learning Objectives

  • Identify opportunities to optimize guideline-directed medical therapy (GDMT) in the treatment of heart failure with reduced ejection fraction.
  • Apply the recent clinical trial findings to the management of patients with heart failure with reduced ejection fraction and co-morbid conditions.
  • Evaluate the use of echocardiogram in the diagnosis and monitoring of heart failure.
  • Build post-discharge planning into the management of heart failure patients hospitalized for acute decompensation.
  • Apply health technology, evidence-based medicine and clinical practice guidelines to navigate heart failure ‘grey areas’.



Chief Department of Medicine CISSS de Lanaudière, Associate Professor of University Laval.
Joliette, Quebec, Canada

Grace Chua, MD, FRCPC, FAC.

Mackenzie Health, Richmond Hill,
Maple, Ontario, Canada